Metabolic HealthClinical TrialPaywall

Age Changes How Cancer Affects Metabolism in Elderly Lung Cancer Patients

French study reveals how aging influences metabolic responses to cancer, potentially explaining malnutrition patterns in elderly patients.

Saturday, March 28, 2026 0 views
Published in ClinicalTrials.gov
Clinical trial visualization: Age Changes How Cancer Affects Metabolism in Elderly Lung Cancer Patients

Summary

A University of Paris study investigated how aging affects metabolic responses to cancer in elderly lung cancer patients. The research aimed to understand why malnutrition develops differently in older cancer patients compared to younger ones. With 27 participants diagnosed with non-small cell lung carcinoma, researchers examined the intersection of age-related metabolic changes and cancer-induced hypermetabolism. The completed study provides insights into how the aging process modifies the body's metabolic response to cancer, potentially explaining unique nutritional challenges faced by elderly cancer patients and informing better treatment approaches.

Detailed Summary

University of Paris researchers completed a specialized study examining how aging influences metabolic responses to cancer in elderly patients with non-small cell lung carcinoma. The investigation addressed a critical gap in understanding why malnutrition manifests differently in older versus younger cancer patients.

The observational study enrolled 27 elderly participants diagnosed with non-small cell lung carcinoma over an 11-month period in 2016. Researchers focused on hypermetabolism, a condition where the body's energy expenditure increases significantly, which commonly occurs in both aging and cancer but through different mechanisms.

The study design allowed investigators to measure metabolic parameters and nutritional status in elderly lung cancer patients, comparing findings against known patterns in younger populations. This approach helped identify age-specific metabolic signatures that could explain increased malnutrition risk in elderly cancer patients.

While specific results weren't detailed in available summaries, the completed status indicates successful data collection on how aging modifies cancer-induced metabolic changes. Understanding these interactions is crucial for longevity medicine, as cancer incidence increases with age and metabolic health directly impacts treatment outcomes and survival.

The findings have significant implications for personalized cancer care in aging populations. By identifying how age influences metabolic responses to cancer, clinicians can better predict nutritional risks and develop targeted interventions. This research contributes to precision medicine approaches that account for age-related physiological changes, potentially improving treatment tolerance and outcomes in elderly cancer patients while supporting healthy aging strategies.

Key Findings

  • Aging and cancer create distinct metabolic changes that interact uniquely in elderly patients
  • Malnutrition mechanisms differ between young and elderly cancer patients
  • Hypermetabolism patterns vary based on age in lung cancer patients
  • Age-specific metabolic signatures may predict nutritional risks in cancer treatment

Methodology

This was an observational study conducted at University of Paris with 27 elderly non-small cell lung carcinoma patients. The study ran for 11 months in 2016, focusing on metabolic measurements without therapeutic interventions.

Study Limitations

Small sample size of 27 participants limits generalizability across diverse elderly populations. Single-center design may not reflect broader healthcare settings, and focus on one cancer type restricts applicability to other malignancies.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.